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Introduction. When a patient has no suitable vessels for use as grafts in bypass or reconstruction procedures, two of the
options available are the use of a cryopreserved vessel or an expanded polytetrafluoroethylene (ePTFE) prosthesis. This study
was designed to compare the long-term behaviour of these vascular substitutes.
Material and methods. We established three study groups by grafting the following vessel substitutes to the iliac artery in
Spraque–Dawley rats: arterial autografts (GI, n ¼ 12), cryopreserved syngenic arterial grafts (cryoisografts) (GII, n ¼ 12),
and ePTFE micrografts (GIII, n ¼ 12). The animals were sacrificed 180 days after surgery, at which time the graft specimens
were morphologically evaluated by light and electron microscopy, immunolabelling (ED1/a-actin) and morphometric
analysis of the neointima.
Results. At the time of sacrifice, graft patency was 100% for the autografts and cryoisografts, while 10% of the ePTFE
micrografts showed fully-occlusive thrombosis. Intimal hyperplasia was observed in grafts in GI and GII; the neointima
being thinner in the cryoisografts (54.36 ^ 2.26 mm) than the autografts (161.30 ^ 3.91 mm). The endothelium formed
over the prosthetic micrografts was unstable, with areas of subendothelial thickening (9.37 ^ 3.18 mm). Cell loss and medial
layer degeneration were observed in both GI and GII specimens, while the GIII grafts were colonised by cells on their luminal
surface.
Conclusions. All three grafts show good long-term tolerance when used in an arterial setting. Following long-term
implant, autografts and cryoisografts show similar alterations that give rise to the complete loss of the muscle component of
the tunica media along with the formation of a stable neointima. This new layer takes on the role of the tunica media.
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Introduction
In arterial reconstruction procedures, the use of
prosthetic material is an option available to the
surgeon when the patient has no suitable vessel.
Expanded polytetrafluoroethylene (ePTFE) is one of
the most frequently used prostheses in human clinical
practice. This biomaterial has several advantages over
other prosthetic materials, including high electrone-
gativity and a hydrophobic surface that reduces
platelet adhesion. This material also boasts a good
blood/biomaterial interface and shows excellent bio-
tolerance on the part of the recipient.1
The incidence of vascular prosthesis failure is high
in a setting of vessels with a small internal diameter.2,3
This is mainly attributable to intimal hyperplasia and
thrombosis. Prosthetic material is also susceptible to
infection, a devastating complication that often
requires its withdrawal and replacement.
Another option that has recently generated much
interest is the use of cryopreserved vessels from
human vessel banks. Over the last few years, these
vessels are being increasingly employed in vascular
reconstruction procedures, given the developments
made in minimising tissue damage induced by low
temperatures. Further advances in the cryopreserva-
tion/thawing process4,5 including the introduction of
cryoprotectants have led to their current use in clinical
practice.6 – 9 Several authors10 – 12 presently use cryo-
preserved vessels for the in situ treatment of infections
provoked by prosthetic materials.
Despite these advances, there is scarce data on the
long-term behaviour of arterial substitutes, bearing in
mind the changes occurring in the repair process itself.
Our experience based on the repair process in
autograft models is that in the long-term,13,14 the
medial layer becomes acellular. The final situation,
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therefore, resembles that related to the use of a
synthetic ePTFE prosthesis whereby the role played
by the graft is to support the vessel wall and act as an
inert conducting tube. The aim of the present study
was, therefore, to compare the long-term behaviour of
cryopreserved arterial grafts with that shown by
ePTFE vascular microprostheses when implanted in
the experimental animal.
Materials and Methods
Experimental animals
The experimental animal used was the female
Sprague – Dawley rat weighing 250 – 300 g. All
procedures were carried out according to European
Union guidelines on the Care and Use of Laboratory
Animals (EEC 28871-22A9). Anaesthesia was
induced by intraperitoneal ketamine chlorohydrate
(0.25 ml/100 g body weight) and diazepam
(0.004 ml/100 g body weight). The surgical approach
was a midline xypho-pubic laparotomy. The common
iliac artery was dissected along its entire course and,
with the help of a Gilbert double vascular clamp, a
segment 5 mm in length was resected from its middle
portion. The length of vessel removed was then
replaced with cryopreserved arterial segments of
similar length harvested from syngenic rats or with
prosthetic ePTFE conduits (W. L. Gore, Flagstaff, AZ,
USA) of 1 mm internal diameter and porosity 30 mm.
The control group was formed by autografts per-
formed in the experimental animals using the same
surgical technique. In this control group, a segment of
similar length (5 mm) was resected from the middle
portion of the iliac artery and immediately reim-
planted in the same position by two end-to-end
anastomoses. A ZEISS 650 microscope was used for
the microsurgery technique used by our team in
previous studies.13,14 In all the surgical procedures,
blood flow was restored by securing the grafts by two
end-to-end anastomoses comprised of loose ethilon
10/0 monofilament (Ethilon, Ethiconw) stitches. Graft
patency was visually confirmed following anastomo-
sis. Though the surgical technique was non-sterile, the
grafts were sterilised in ethylene oxide prior to
implant. Neither local nor general anticoagulation
was used.
Cryopreserving and thawing the arterial grafts
Iliac arteries harvested from donor animals were
washed in minimum essential medium (MEM) to
remove all traces of blood and placed in cryotubes
containing the same medium supplemented with 20%
foetal bovine serum (FBS) and 10% dimethylsulph-
oxide (DMSO). To reduce its toxicity, the DMSO was
added in 4 £ 5 min steps in which its concentration
was increased to 10%. The vessels were subjected to
automated, controlled freezing in a biological freezer
(CM25 P.115, Carburos Meta´licos S.A., Spain) at a
mean temperature reduction rate of 1 8C/min to
2120 8C.
The frozen arterial segments were stored in
liquid nitrogen vapour at 2145 8C for 30 days.
After this storage period, the specimens were
transferred from the liquid nitrogen tank to the
freezing chamber where they were thawed accord-
ing to a slow, automated thawing programme
established in our laboratory5,15 at a warming rate
of 1 8C/min to room temperature. Once thawed,
the cryoprotectant was removed gradually in tapered
dilutions and the cryografts implanted in syngenic
recipients to avoid rejection.
Experimental design
The animals were grouped according to the type of
graft implanted as:
GI ðn ¼ 12Þ: fresh arterial autografts
GII ðn ¼ 12Þ: cryopreserved arterial isografts
GIII ðn ¼ 12Þ: ePTFE micrografts.
The animals were sacrificed at 180 days post-
surgery. Just before sacrifice, they were reoperated
on to perfuse the vascular tree (at a pressure of
100 mmHg via a catheter placed in the left ventricle),
first with Ringer’s lactate, to wash out all the blood,
and then with the appropriate solution for the
subsequent analysis. All the explanted grafts were
tested for infection at the time of extraction.
Morphological evaluation
Grafts for light microscopy examination were per-
fused with 10% formaldehyde and embedded in
paraffin to obtain sections 5 mm-thick. Once deparaffi-
nated and hydrated, the specimens were stained with
haematoxylin-eosin, orcein and Masson’s trichrome
stains.
For ultrastructural analysis, the solution used for
graft perfusion was a 2:1 mixture of glutaraldehyde
(3%) – paraformaldehyde (2%) in Millonig buffer
(pH 7.3), to avoid tissue retraction and achieve good
fixing. After the perfusion process, the grafted
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segment was removed along with a small band of
recipient artery at each end of the graft. Small graft
fragments were then fixed for 1 h in 3% glutaralde-
hyde, stored in Millonig buffer (pH 7.3) and postfixed
in 2% osmium tetroxide. Once dehydrated in a graded
series of acetone, the specimens were embedded in
Araldite to obtain thin cuts. These sections were
counterstained with lead citrate and examined using
a Zeiss 109 transmission electron microscope.
For scanning electron microscopy (SEM), the graft
specimens were opened longitudinally and immersed
in 3% glutaraldehyde. Next, they were transferred to
Millonig buffer (pH 7.3) for 1 h and dehydrated in a
graded acetone series reaching critical point in a
Polaron E 3000 instrument with CO2. Once metallised
with palladium–gold, the specimens were examined
using a Zeiss 950 DSM scanning electron microscope.
Immunohistochemical analysis
Antibodies specific for rat monocytes/macrophages
(MCA 341, Serotec) and smooth muscle cells
(a-actin, Sigma) were used in the alkaline phos-
phatase-labelled avidin – biotin procedure. The
chromogenic substrate contained alpha-naphtol
and fast-red. Nuclei were counterstained with Carazzi
haematoxylin.
Morphometry and cell quantification
Morphometric measurements were made using a
Microm computerised image analyser (Microm) on
10 transverse tissue sections per specimen examined
under the 40 £ lens of the light microscope. Each
section was divided into 4 sectors and an optical field
was randomly selected from each sector for ED1-
positive cell counts and to measure the thickness of the
neointima.
The thickness of the neointima was determined in
sections of the grafts stained with orcein, haematoxy-
lin-eosin or Masson’s trichrome stains, as the distance
from the endothelial layer to the internal elastic
lamina, which forms the border with the medial layer.
Fig. 1. (a) Light microphotograph of an autograft showing a fairly thickened neointima (IH) and an acellular tunica media (M)
comprised of elastic laminae embedded in a degenerated extracellular matrix (LM; 400 £ ). (b) Scanning electron microscopy
image of the same specimen in which a perfectly formed continuous endothelium (E) is observed (SEM; 1000 £ ). (c)
Ultrastructure of the proliferative smooth muscle cells that make up the neointima of the grafts (L, lumen; IEL, internal elastic
laminae) (TEM; 3000 £ ).
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Statistical analysis
Statistical analysis was performed using non-para-
metric statistics. The thickness of the neointima and
the proportion of ED1-positive cells were compared
among the study groups by the Mann–Whitney
U-test. The level of significance was set at p , 0:05:
Results
At the time of extraction, all the autografts (GI) and
cryoisografts (GII) were patent, though one of the GII
grafts was partially thrombosed. In contrast, 10% of
the ePTFE prostheses (GIII) showed fully occlusive
thrombosis at the time of sacrifice. None of the 36
explanted grafts showed signs of infection.
Morphological analysis
In the autografts, the neointima was fairly thick
(Fig. 1(a)) and extended across both the grafted
segment and adjacent areas of the recipient artery.
This new arterial tunica was formed by a monolayer of
endothelial cells (Fig. 1(b)) and several strata of
proliferative smooth muscle cells lining the luminal
surface (Fig. 1(c)). Around these layers and infilling
intercellular spaces, small amounts of extracellular
matrix with disperse elastin deposits were identified.
The myointima extended across the clamped section of
the artery, completely covering the suture stitches. The
thickness of this neolayer was greater than that of the
native muscle layer. The latter had changed its
morphology to become an acellular layer containing
elastic laminae, which take up the appearance of piles
Fig. 2. (a) Cryoisografts show a neointima (IH) of similar thickness to the tunica media (M). The muscle layer shows thinning
and a lack of cells (LM; 400 £ ). (b) The luminal surface of the grafted cryopreserved segment is formed by an uninterrupted,
uniform endothelium (E). The image shows the thickness of the three graft layers (IH; neointima, M; media and A; adventitia)
and the site of anastomosis (S) (SEM; 200 £ ). (c) In this TEM image, intimal cells (E) of typical elongated morphology and a
tunica media (M) of degenerated appearance can be observed (TEM; 4000 £ ).
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of coins embedded in an extracellular matrix made up
of debris (Fig. 1(a)).
The arterial cryoisografts were covered by a
concentric neointima several cell layers thick
(Fig. 2(a)). The luminal surface of the grafted segment
was formed by a continuous, uniform endothelium
(Fig. 2(b)). These intimal cells showed the typical
elongated morphology (Fig. 2(c)). The medial layer of
the graft was degenerated with complete cell loss
(Fig. 2(c)). Its general appearance was one of a thinned,
acellular layer that was almost exclusively made up of
elastic laminae, some of which were fragmented. The
different elastic laminae were organised as tight
bundles of fibres that ran parallel and concentric to
the vessel lumen. Between laminae it was barely
possible to discern thin bands of interstitial matrix
separating them, in which only filamentous elements
and amorphous material could be seen.
After 6 months of implant, the inside of the ePTFE
microprostheses had become colonised with cells
(Fig. 3(a)) and, in zones close to the sites of
anastomoses, small neoformed capillaries were
observed in the prosthetic interstices. The endothelial
lining formed on the grafted prosthesis was somewhat
unstable, showing areas comprised of smooth muscle
cells that formed the neointima, interspersed with
other zones of cell loss and white blood cell infiltration
(Fig. 3(b) and (c)). In some specimens, the myointima
persisted as an irregular flap made up of several cell
strata. Electron microscopy revealed how the ePTFE
maintained its normal structure 180 days after
implant, with no signs of degeneration whatsoever.
The ends of the recipient artery showed similar
features to those corresponding to the other study
groups.
Morphometry results
Morphometric measurements revealed that intimal
hyperplasia was considerably reduced in the grafts
subjected to cryopreservation (GII) compared to
the autografts (GI). In group I, the mean thickness of
the neointima was 161 ^ 4 mm (mean ^ SD), while
this measurement was 54 ^ 2 mm for the cryoisografts;
the difference between the two groups being statisti-
cally significant ðp , 0:05Þ: Intimal hyperplasia was
further reduced in the ePTFE graft segments which
showed a myointimal thickness of 9 ^ 3 mm such that
differences between GIII and GI ðp , 0:001Þ and
Fig. 3. (a) Light microphotograph of an ePTFE micrograft showing intense cell colonisation of the inner prosthesis (LM;
400 £ ). (b) White blood cells (P) appear on the luminal surface of some specimens (LM; 400 £ ). (c) Zones of endothelial cell
loss on the ePTFE surface (*) showing adhered white blood cells (P) 180 days after implant (E, endothelium) (SEM; 10000 £ ).
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between GII and GIII ðp , 0:05Þ were also significant
(Table 1).
Immunohistochemistry
Immunohistochemical analysis performed using the
ED1 antibody (MCA341), specific for rat macro-
phages enabled us to confirm the persistence of
this cell type when arterial replacement was
undertaken using the prosthetic micrografts (GIII)
(Table 1). In this case, 13% ^ 1 (mean ^ SD) of the
cells were ED1-positive and could be seen to
infiltrate the prosthetic interstices (Fig. 4(a)), the
tunica adventitia (Fig. 4(b)) and the luminal
surface. Lowest numbers were recorded for the
autografts (GI), which showed a proportion of
2% ^ 0.6 in hyperplasic areas (Fig. 4(c)), mainly
close to the suture sites, and in the adventitia. The
previously cryopreserved grafts (GII) showed
values closer to those for GI (3% ^ 0.3), with
macrophages also showing a preference for areas
Table 1. Neointimal thickness (microns) and proportion of inflammatory cells (%) in the implanted graft segments (mean 6 SD)
n Neointimal thickness (microns) Inflammatory cells (ED1 þ ) (%)
Group I (autografts) 12 161 ^ 4 2 ^ 0.6*
Group II (cryoisografts) 12 54 ^ 2† 3 ^ 0.3*
Group III (ePTFE micrografts) 12 9 ^ 3‡ 13 ^ 1
*p , 0:05; compared to Group III.
†p , 0:05; compared to Group I and Group III.
‡p , 0:001; compared to Group I.
Fig. 4. ED1-positive cells ( ! ) infiltrate the interstices of the ePTFE grafts (a) (LM; 630 £ ) and the adventitia (b) (LM; 630 £ ).
In most of the autografts, labelled cells were observed on the luminal surface or in zones of intimal hyperplasia close to the
sites of anastomosis (c) (LM; 1000 £ ). In the cryoisografts, macrophages showed a preference for areas of hyperplasia (IH) (d)
(LM; 1000 £ ) or suture (S) (e) (LM; 630 £ ).
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of hyperplasia (Fig. 4(d)) and sites of anastomosis
(Fig. 4(e)). These last groups (GI and II) did not
vary amongst each other in terms of ED1-positive
cells but both differed significantly ðp , 0:05Þ when
compared to the ePTFE group.
Differentiated smooth muscle cells were identified
using the anti a-actin antibody. These cells comprised
the tunica neointima in groups I and II (Fig. 5(a) and
(b)). In the ePTFE micrografts, a-actin-positive cells
formed part of the hyperplasia in zones in which it
was apparent (Fig. 5(c)), and were also observed
within the prosthetic material (Fig. 5(d) and (e)). Areas
of angiogenesis were observed in the ePTFE inter-
stices, in which the cells comprising the vessels in the
inner prosthesis became labelled with the antibody for
a-actin (Fig. 5(d)).
Discussion
In this experimental study, we were able to confirm the
excellent patency of both the autografts and cryopre-
served grafts, which was reduced in the group of
ePTFE implants. Similar patency rates have been
described using cryopreserved grafts,16,17 though
those reported for ePTFE are generally lower,18,19
mainly due to thrombosis.
The hyperplasic response shown by the three graft
models has been inconsistent. In the autografts, an
almost consolidated hyperplasia can be observed three
months after implant, while this response is signifi-
cantly delayed in cryopreserved grafts. In similar
experiments performed by Motomura et al.20 using
fresh and cryopreserved grafts, similar cell loss was
Fig. 5. The neointimal layer (IH) in specimens from groups I (a) (LM; 1000) and II (b) (LM; 630 £ ) is comprised of
differentiated smooth muscle cells labelled with the anti a-actin antibody. In the ePTFE group, however, labelled cells were
found in areas of hyperplasia (IH) (c) (LM; 630 £ ), such as inside the prosthesis (e) (LM; 630 £ ) and at sites of angiogenesis (*)
(d) (LM; 40 £ ) (IH; intimal hyperplasia, M; tunica media).
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observed in the medial layer but cryopreserved grafts
showed the opposite outcome of a faster hyperplasic
response. This difference could be attributable to the
rat strain or vascular setting of the implanted grafts.
Others16 have reported good long-term results for the
use of cryoisografts as conduits as well as considerable
intimal hyperplasia in Fisher rats grafted in the
femoral artery setting. Prosthetic ePTFE grafts also
induce the delayed formation of the myointima with
its greatest thickness achieved three months after
implant,21 followed by a drop in thickness.
This different development of the myointima
shown in the three models could be related to cell
behaviour in the medial layer. In the autografts, since
this layer is complete and is only subjected to transient
ischaemia during grafting, smooth muscle cell
migration towards the subintimal space is promoted.
In contrast, in the cryopreserved grafts, the cryopre-
servation process itself provokes intense and irrevers-
ible structural changes to the smooth muscle cells
resulting in their death.4 This event is confirmed by the
findings of other authors,22 who noted a significant
drop in the number of cells of the medial layer
following cryopreservation. This would suggest that
after grafting, the already altered media of the
cryograft is unable to quickly generate a neointima,
explaining its delayed appearance. In this case, the
neointima probably forms at the expense of the
recipient artery ends. The autografts also undergo
degeneration of the media, but this occurs much later
than in the cryografts.12 In a recent study, Giglia et al.23
also observed diminished smooth muscle cell pro-
portions in the medial layer, both in autografts and
cryografts.
In the ePTFE grafts, hyperplasia commences at the
ends of the recipient artery as occurs in the cryopre-
served grafts. A neoadventitia is also generated
outside the prosthesis such that the biomaterial
becomes trapped in a pocket that takes on the role of
the medial layer.
Our hypothesis on the repair process in the three
models is that in the long-term, the cell-lacking medial
layer in both autografts and cryografts could resemble
the synthetic ePTFE prosthesis, given its role is to
support the vascular wall and act as an inert
conducting tube. In the autografts, the myointimal
layer itself would take on the role of the medial layer.14
In conclusion, all three vessel substitutes show good
long-term tolerance when used in an arterial setting.
Following long-term implant, autografts and cryoiso-
grafts show similar alterations that give rise to the
complete loss of the muscle component of the tunica
media along with the formation of a stable neointima.
This new layer takes on the role of the tunica media.
Similar behaviour is shown when the arterial medial
layer is replaced with ePTFE. After grafting an arterial
substitute, the newly formed intima constitutes the
repair response that restores the homeostatic continu-
ity of the arterial graft.
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